Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| PharmaEssentia 6446.TW | Pharmaceuticals: Major | $15.8B | +7% | +118% | +64% | 38% | 39.2× |
| Lin BioScience 6696.TWO | Biotechnology | $3.74B | +36% | +129% | n/a | n/a | n/a |
| Caliway Biopharmaceuticals 6919.TW | Biotechnology | $3.01B | -19% | -37% | -54% | -6,983% | n/a |
| TLC BioSciences 7924.TWO | Biotechnology | $1.57B | -18% | n/a | n/a | n/a | n/a |
| Bora Pharmaceuticals 6472.TW | Pharmaceuticals: Other | $1.55B | -5% | -2% | -6% | 15% | 14.2× |
| PELL Bio-Med Technology 6949.TW | Biotechnology | $1.49B | +67% | +126% | +5% | -1,720% | n/a |
| Lotus Pharmaceutical 1795.TW | Pharmaceuticals: Major | $1.34B | -6% | -26% | +49% | 24% | 8.4× |
| Center Laboratories 4123.TWO | Pharmaceuticals: Major | $676M | -9% | -28% | +4% | 5% | n/a |
| Oneness Biotech 4743.TWO | Pharmaceuticals: Major | $652M | -5% | -21% | +37% | -510% | n/a |
| SunMax Biotechnology 4728.TWO | Medical Specialties | $643M | -2% | +1% | +12% | 50% | n/a |
| TTY Biopharm 4105.TWO | Pharmaceuticals: Major | $596M | +1% | +7% | +5% | 33% | 10.9× |
| Handa Pharmaceuticals 6620.TWO | Pharmaceuticals: Major | $525M | -28% | +43% | +68% | 37% | 21.6× |
| HanchorBio 7827.TW | Biotechnology | $511M | -28% | n/a | n/a | -225% | 2.5× |
| Scinopharm Taiwan 1789.TW | Biotechnology | $482M | +9% | -1% | -5% | -4% | 43.8× |
| CHO Pharma 6586.TWO | Biotechnology | $480M | -38% | +57% | -47% | -17,694% | n/a |
| Elixiron Immunotherapeutics (Cayman) 7871.TWO | Pharmaceuticals: Major | $477M | -21% | +62% | +10,947% | -194% | n/a |
| YungShin Global 3705.TW | Pharmaceuticals: Major | $474M | +4% | +7% | -8% | 15% | n/a |
| Medigen Vaccine Biologics 6547.TWO | Biotechnology | $467M | -22% | -5% | +44% | 10% | 187.6× |
| Steminent Biotherapeutics 7729.TWO | Biotechnology | $458M | -13% | +139% | n/a | n/a | n/a |
| TaiMed Biologics 4147.TWO | Biotechnology | $454M | -8% | +10% | +4% | -30% | n/a |
| Synmosa Biopharma 4114.TWO | Pharmaceuticals: Major | $442M | -6% | +2% | +11% | 11% | n/a |
| Ever Supreme Bio Technology 6712.TWO | Biotechnology | $439M | -10% | +9% | +13% | 47% | 28.6× |
| EirGenix 6589.TW | Biotechnology | $427M | -8% | +2% | +27% | -71% | n/a |
| Excelsior Medical 4104.TW | Medical Distributors | $409M | 0% | +1% | +6% | 8% | n/a |
| Taidoc Technology 4736.TW | Medical Specialties | $395M | -2% | 0% | -6% | 18% | n/a |
| Gongwin Biopharm 6617.TWO | Medical Distributors | $388M | -21% | +50% | +22% | -571% | n/a |
| Grape King Bio 1707.TW | Pharmaceuticals: Other | $361M | -5% | -28% | -7% | 20% | 11.0× |
| Lumosa Therapeutics 6535.TWO | Pharmaceuticals: Major | $356M | -17% | -49% | -8% | -883% | n/a |
| Daiken Biomedical 7780.TW | Pharmaceuticals: Other | $352M | -9% | -24% | n/a | 18% | n/a |
| ACRO Biomedical 6748.TWO | Medical Specialties | $347M | -24% | +129% | +45% | -178% | n/a |
| Foresee Pharmaceuticals 6576.TWO | Pharmaceuticals: Major | $343M | -8% | -9% | +6% | -104% | n/a |
| AP Biosciences 6945.TWO | Biotechnology | $330M | -14% | -32% | -100% | n/a | n/a |
| Standard Chemical & Pharmaceutical 1720.TW | Pharmaceuticals: Major | $329M | -1% | 0% | +3% | 21% | n/a |
| Universal Vision Biotechnology 3218.TWO | Medical/Nursing Services | $324M | -5% | -7% | 0% | 31% | 9.6× |
| 6467 6467.TW | Pharmaceuticals: Major | $322M | n/a | n/a | n/a | -2,618% | n/a |
| TCI 8436.TWO | Pharmaceuticals: Other | $320M | -13% | -24% | -2% | 18% | 10.0× |